114 related articles for article (PubMed ID: 10852346)
1. Umbilical cord endothelial cells expressing large T antigen: comparison with primary cultures and effect of cell age.
Fitzgerald U; Hettle S; MacDonald C; McLean JS
In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):222-7. PubMed ID: 10852346
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immortalized human umbilical and iliac vein endothelial cell lines after transfection with SV40 large T-antigen.
van Leeuwen EB; Veenstra R; van Wijk R; Molema G; Hoekstra A; Ruiters MH; van der Meer J
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):15-25. PubMed ID: 10691096
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of immortalized human coronary endothelial cells.
Nakano R; Murahashi N; Sasaguri Y; Tanimoto A; Soejima M; Arima N; Hamada T
Biochem Mol Biol Int; 1995 Jul; 36(4):715-22. PubMed ID: 8528134
[TBL] [Abstract][Full Text] [Related]
4. Establishment of permanent human endothelial cells achieved by transfection with SV40 large T antigen that retain typical phenotypical and functional characteristics.
Moldovan F; Benanni H; Fiet J; Cussenot O; Dumas J; Darbord C; Soliman HR
In Vitro Cell Dev Biol Anim; 1996 Jan; 32(1):16-23. PubMed ID: 8835314
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
6. Human endothelial cells transfected by SV40 T antigens: characterization and potential use as a source of normal endothelial factors.
Lassalle P; LaGrou C; Delneste Y; Sanceau J; Coll J; Torpier G; Wietzerbin J; Stehelin D; Tonnel AB; Capron A
Eur J Immunol; 1992 Feb; 22(2):425-31. PubMed ID: 1347014
[TBL] [Abstract][Full Text] [Related]
7. In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Pourtau J; Soria C; Paysant J; Vannier JP; Vasse M
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):609-15. PubMed ID: 9863709
[TBL] [Abstract][Full Text] [Related]
8. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.
Chen PR; Lee CC; Chang H; Tsai CE
J Nutr Biochem; 2005 Jan; 16(1):59-64. PubMed ID: 15629242
[TBL] [Abstract][Full Text] [Related]
9. Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells.
Takahashi K; Uwabe Y; Sawasaki Y; Kiguchi T; Nakamura H; Kashiwabara K; Yagyu H; Matsuoka T
Am J Physiol; 1998 Jul; 275(1):L47-54. PubMed ID: 9688934
[TBL] [Abstract][Full Text] [Related]
10. Cell adhesion markers are expressed by a stable human endothelial cell line transformed by the SV40 large T antigen under vimentin promoter control.
Vicart P; Testut P; Schwartz B; Llorens-Cortes C; Perdomo JJ; Paulin D
J Cell Physiol; 1993 Oct; 157(1):41-51. PubMed ID: 8408241
[TBL] [Abstract][Full Text] [Related]
11. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
[TBL] [Abstract][Full Text] [Related]
12. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
Konkle BA; Ginsburg D
J Clin Invest; 1988 Aug; 82(2):579-85. PubMed ID: 3136192
[TBL] [Abstract][Full Text] [Related]
13. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
14. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
15. Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von Willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18.
Morganti M; Mittermayer C; Henze U; Carpi A; Sagripanti A
Biomed Pharmacother; 1996; 50(8):373-5. PubMed ID: 8952858
[TBL] [Abstract][Full Text] [Related]
16. Human endothelial cells expressing polyoma middle T induce tumors.
Primo L; Roca C; Ferrandi C; Lanfrancone L; Bussolino F
Oncogene; 2000 Jul; 19(32):3632-41. PubMed ID: 10951569
[TBL] [Abstract][Full Text] [Related]
17. Isolation, cultivation, and partial characterization of microvascular endothelium derived from human lung.
Carley WW; Niedbala MJ; Gerritsen ME
Am J Respir Cell Mol Biol; 1992 Dec; 7(6):620-30. PubMed ID: 1333246
[TBL] [Abstract][Full Text] [Related]
18. Alpha-tocopherol, a potent modulator of endothelial cell function.
Huang N; Lineberger B; Steiner M
Thromb Res; 1988 May; 50(4):547-57. PubMed ID: 3137680
[TBL] [Abstract][Full Text] [Related]
19. Immortalization of human umbilical vein endothelial cells with telomerase reverse transcriptase and simian virus 40 large T antigen.
Bian C; Zhao K; Tong GX; Zhu YL; Chen P
J Zhejiang Univ Sci B; 2005 Jul; 6(7):631-6. PubMed ID: 15973764
[TBL] [Abstract][Full Text] [Related]
20. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
